Fingolimod Mylan Unjoni Ewropea - Kroat - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - финголимод hidroklorid - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 i 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Arlesias 0,5 mg tvrde kapsule Kroazja - Kroat - HALMED (Agencija za lijekove i medicinske proizvode)

arlesias 0,5 mg tvrde kapsule

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - fingolimodklorid - kapsula, tvrda - urbroj: jedna kapsula sadrži 0,5 mg fingolimoda (u obliku klorida).

Inzolfi 0,25 mg tvrde kapsule Kroazja - Kroat - HALMED (Agencija za lijekove i medicinske proizvode)

inzolfi 0,25 mg tvrde kapsule

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - fingolimodklorid - kapsula, tvrda - urbroj: jedna tvrda kapsula sadrži 0,25 mg fingolimoda (u obliku fingolimodklorida)

FINGOLIMOD STADA 0.5mg Kapsula, tvrda - Kroat - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

fingolimod stada 0.5mg kapsula, tvrda

hemofarm a.d. vrŠac p.j. podgorica - fingolimod - kapsula, tvrda - 0.5mg

Idefirix Unjoni Ewropea - Kroat - EMA (European Medicines Agency)

idefirix

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresivi - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

ESTRELA 0,56 mg/1 kapsula kapsula, tvrda Bożnija Ħerżegovina - Kroat - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

estrela 0,56 mg/1 kapsula kapsula, tvrda

proton med d.o.o. banja luka - финголимод - kapsula, tvrda - 0,56 mg/1 kapsula - 1 kapsula, tvrda sadrži: 0,5 mg fingolimoda (u obliku 0,56 mg fingolimod hidrohlorida)

ESTRELA 0.5mg Kapsula, tvrda - Kroat - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

estrela 0.5mg kapsula, tvrda

"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - fingolimod - kapsula, tvrda - 0.5mg